The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

psychnostics.com

Stage

Incubator/Accelerator | Alive

About PsychNostics

PsychNostics, LLC has developed a diagnostic blood test for Bipolar Disorder and ADHD. This propreitory test uses the Membrane Potential Ratio ( MPR ) as a diagnostic blood test marker for Bipolar Disorder (BPD) and Attention Deficit Hyper Active Disorder (ADHD). The test results have been published in peer reviewed scientific journals. Clinical psychiatrists have validated the reliability of this test through clinical trials. PsychNostics, LLC is currently engaged in the development of broader uses of this technology nationwide. Further research is underway to elucidate the biological pathway and the proteins involved so that they could be used as drug targets for developing more effective drugs for these illnesses. Efforts are being made to partner co-development and marketing arrangements with other companies to develop these technologies.

PsychNostics Headquarter Location

Baltimore, Maryland, 21201,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

PsychNostics Patents

PsychNostics has filed 9 patents.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Abnormal psychology
  • Amphetamine
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/26/2016

7/30/2019

Ion channels, Electrophysiology, Psychiatric diagnosis, Neurophysiology, Transcription factors

Grant

Application Date

9/26/2016

Grant Date

7/30/2019

Title

Related Topics

Ion channels, Electrophysiology, Psychiatric diagnosis, Neurophysiology, Transcription factors

Status

Grant

  • Where is PsychNostics's headquarters?

    PsychNostics's headquarters is located at Baltimore.

  • What is PsychNostics's latest funding round?

    PsychNostics's latest funding round is Incubator/Accelerator.

  • Who are the investors of PsychNostics?

    Investors of PsychNostics include bwtech@UMBC Incubator & Accelerator.

  • Who are PsychNostics's competitors?

    Competitors of PsychNostics include Ikonisys, iMMCO Diagnostics, ContraVac, Affinergy, Daktari Diagnostics and 10 more.

You May Also Like

L
Lumiphore

Lumiphore is a research company developing lanthanide technology for use in high-value applications and commercializing the technology by entering into market-specific alliances with corporate partners. Lumiphore develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a combination of sensitivity, reliability, flexibility and high throughput.

Proterixbio Logo
Proterixbio

ProterixBio develops products to transform the management of chronic diseases.

i
iMMCO Diagnostics

IMMCO Diagnostics provides high-quality diagnostic test kits and lab testing services worldwide for the screening of autoimmune disorders. IMMCO Diagnostics incorporates working on research, clinical laboratory expertise, and medical devices into an approach to autoimmune diagnostics.

C
Cellatope Corporation

Cellatope is a cell analysis company that is developing research and diagnostic products and services in the field of autoimmune and inflammatory disease, with an initial focus on lupus and transplant medicine.

C
Clinical Laboratory Partners

Clinical Laboratory Partners is a provider of clinical diagnostic testing services for healthcare providers, both hospitals and private practices, effectively competing in local markets against a range of national and other local clinical diagnostic laboratories.

K
Knoesis

Knoesis seeks to develop bio-analytical hardware and reagents enabling cost-effective clinical diagnostics. The vision of the company is to allow everyone affordable access to rapid and specific diagnostic healthcare knowledge. Knoesis' first application is an immunosensor for the detection of latent tuberculosis infection.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.